Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1

被引:26
|
作者
Hu, Hao [1 ]
Luo, Cheng [2 ]
Zheng, Y. George [1 ]
机构
[1] Univ Georgia, Dept Pharmaceut & Biomed Sci, 250 W Green St, Athens, GA 30602 USA
[2] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
基金
美国国家卫生研究院;
关键词
ASYMMETRIC DIMETHYLARGININE; SUBSTRATE-SPECIFICITY; FUNCTIONAL INSIGHTS; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; KIDNEY-DISEASE; PRMT1; METHYLATION; INHIBITORS; CARM1;
D O I
10.1074/jbc.M116.757625
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methyltransferases (PRMTs) are the enzymes responsible for posttranslational methylation of protein arginine residues in eukaryotic cells, particularly within the histone tails. A detailed mechanistic model of PRMT-catalyzed methylation is currently lacking, but it is essential for understanding the functions of PRMTs in various cellular pathways and for efficient design of PRMT inhibitors as potential treatments for a range of human diseases. In this work, we used stopped-flow fluorescence in combination with global kinetic simulation to dissect the transient kinetics of PRMT1, the predominant type I arginine methyltransferase. Several important mechanistic insights were revealed. The cofactor and the peptide substrate bound to PRMT1 in a random manner and then followed a kinetically preferred pathway to generate the catalytic enzyme-cofactor-substrate ternary complex. Product release proceeded in an ordered fashion, with peptide dissociation followed by release of the byproduct S-adenosylhomocysteine. Importantly, the dissociation rate of the monomethylated intermediate from the ternary complex was much faster than the methyl transfer. Such a result provided direct evidence for distributive arginine dimethylation, which means the monomethylated substrate has to be released to solution and rebind with PRMT1 before it undergoes further methylation. In addition, cofactor binding involved a conformational transition, likely an open-to-closed conversion of the active site pocket. Further, the histone H4 peptide bound to the two active sites of the PRMT1 homodimer with differential affinities, suggesting a negative cooperativity mechanism of substrate binding. These findings provide a new mechanistic understanding of how PRMTs interact with their substrates and transfer methyl groups.
引用
收藏
页码:26722 / 26738
页数:17
相关论文
共 50 条
  • [41] Protein arginine methyltransferase 1 interacts with Gli1 and regulates its transcriptional activity
    Zhou, Weizheng
    Qin, Wenxing
    Qiao, Fan
    Xu, Zhiyun
    Yuan, Yang
    Chen, Hezhong
    TUMOR BIOLOGY, 2016, 37 (07) : 9071 - 9076
  • [42] Investigating the binding preferences of small molecule inhibitors of human protein arginine methyltransferase 1 using molecular modelling
    Hong, Wei
    Li, Jingyang
    Laughton, Charles A.
    Yap, Lee Fah
    Paterson, Ian C.
    Wang, Hao
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2014, 51 : 193 - 202
  • [43] Protein Arginine Methyltransferase 1 Interacts With PGC1α and Modulates Thermogenic Fat Activation
    Qiao, Xiaona
    Kim, Dong-il
    Jun, Heejin
    Ma, Yingxu
    Knights, Alexander J.
    Park, Min-Jung
    Zhu, Kezhou
    Lipinski, Jay H.
    Liao, Jiling
    Li, Yiming
    Richard, Stephane
    Weinman, Steven A.
    Wu, Jun
    ENDOCRINOLOGY, 2019, 160 (12) : 2773 - 2786
  • [44] A peptoid-based inhibitor of protein arginine methyltransferase 1 (PRMT1) induces apoptosis and autophagy in cancer cells
    Brekker, Mollie A.
    Sartawi, Tala
    Sawatzky, Tina M.
    Causey, Corey P.
    Rehman, Fatima Khwaja
    Knuckley, Bryan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (08)
  • [45] A novel splicing isoform of protein arginine methyltransferase 1 (PRMT1) that lacks the dimerization arm and correlates with cellular malignancy
    Patounas, Odysseas
    Papacharalampous, Ioanna
    Eckerich, Carmen
    Markopoulos, Georgios S.
    Kolettas, Evangelos
    Fackelmayer, Frank O.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (02) : 2110 - 2123
  • [46] Essential Role of Protein Arginine Methyltransferase 1 in Pancreas Development by Regulating Protein Stability of Neurogenin 3
    Lee, Kanghoon
    Kim, Hyunki
    Lee, Joonyub
    Oh, Chang Myung
    Song, Heein
    Kim, Hyeongseok
    Koo, Seung Hoi
    Lee, Junguee
    Lim, Ajin
    Kim, Hail
    DIABETES & METABOLISM JOURNAL, 2019, 43 (05) : 649 - 658
  • [47] A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control
    Ma, Yingxu
    Liu, Shanshan
    Jun, Heejin
    Wang, Jine
    Fan, Xiaoli
    Li, Guobing
    Yin, Lei
    Rui, Liangyou
    Weinman, Steven A.
    Gong, Jianke
    Wu, Jun
    FASEB JOURNAL, 2020, 34 (11) : 14863 - 14877
  • [48] Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1
    Hendrickson-Rebizant, Thordur
    Sudhakar, Sadhana R. N.
    Rowley, Michael J.
    Frankel, Adam
    Davie, James R.
    Lakowski, Ted M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (18) : 15931 - 15946
  • [49] Effect of protein arginine methyltransferase-1 inhibition on hypoxia-induced vasoconstriction
    Kumarasamy, Chellan
    Singh, Gurpreet
    Raman, Pachaiappan
    Mala, Kanchana
    MEDICAL HYPOTHESES, 2015, 85 (06) : 740 - 743
  • [50] Elevated protein arginine methyltransferase 1 expression regulates fibroblast motility in pulmonary fibrosis
    Zakrzewicz, Dariusz
    Zakrzewicz, Anna
    Didiasova, Miroslava
    Korencak, Marek
    Kosanovic, Djuro
    Schermuly, Ralph T.
    Markart, Philipp
    Wygrecka, Malgorzata
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (12): : 2678 - 2688